Trinity Biotech Investor Relations Material
Latest events
Q3 2024
Trinity Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Trinity Biotech plc
Access all reports
Trinity Biotech plc. focuses on the development, manufacturing, and marketing of diagnostic products for the clinical laboratory and point-of-care segments. The company's product portfolio includes diagnostic tests for infectious diseases, diabetes, hemoglobin disorders, and autoimmune conditions. Trinity Biotech serves healthcare providers, laboratories, and patients worldwide, offering reliable and high-quality diagnostic solutions. The company is headquartered in Bray, Ireland, and its shares are listed on the NASDAQ.
Latest articles
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
Ticker symbol
TRIB
Country
🇺🇸 United States